|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/10 | |
| A61K 31/5377 | |||
| A61K 31/7068 | |||
| A61P 35/00 |
| (11) | Number of the document | 3062809 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14802211.4 |
| Date of filing the European patent application | 2014-10-30 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2014/050939 |
| Date | 2014-10-30 |
| (87) | Number | WO 2015/063768 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361897921 P | 2013-10-31 | US | |
| 201461945302 P | 2014-02-27 | US |
| (72) |
PELED, Amnon, IL
ABRAHAM, Michal, IL
|
| (73) |
Biokine Therapeutics Ltd.,
Building 13a Einstein Street, Science Park Kiryat Weizmann, 7403617 Nes Ziona,
IL
BioLineRx Ltd., 2 HaMaayan Street, 7177871 Modiin, IL |
| (54) | A CXCR4 PEPTIDE INHIBITOR FOR USE IN TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION |
| A CXCR4 PEPTIDE INHIBITOR FOR USE IN TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION |